532Wire StoriesBOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies These engineered...
- 496Wire Stories
Andersen Global Inducts Member Firms in Georgia
SAN FRANCISCO–(BUSINESS WIRE)–#agexpansion–Andersen Global continues to solidify its international presence as Andersen in Georgia (formerly Prime Tax LLC) debuts in the Central...
- 481Wire Stories
Andersen Global Inducts Member Firms in Georgia
SAN FRANCISCO–(BUSINESS WIRE)–#agexpansion–Andersen Global continues to solidify its international presence as Andersen in Georgia (formerly Prime Tax LLC) debuts in the Central...
- 601Wire Stories
BOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies These engineered...
- 490Wire Stories
BOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies These engineered...
- 523Wire Stories
Credo Introduces Industry Leading 40Gbps PAM3 SerDes Technology To Address New Markets Requiring High-speed, Low-Power Connectivity
SAN JOSE, Calif.–(BUSINESS WIRE)–Credo Technology Group Holding Ltd (NASDAQ: CRDO) today announced the availability of its Ostrich 40G, PAM3 Serializer/Deserializer (SerDes) PHY/PMA...
- 490Wire Stories
REA Group Hosts First Investor Day
Outlines Significant Growth Opportunities with Strong Momentum in Core Business and Adjacencies NEW YORK–(BUSINESS WIRE)–REA Group is targeting “double-digit revenue and EBITDA...
- 496Wire Stories
Credo Introduces Industry Leading 40Gbps PAM3 SerDes Technology To Address New Markets Requiring High-speed, Low-Power Connectivity
SAN JOSE, Calif.–(BUSINESS WIRE)–Credo Technology Group Holding Ltd (NASDAQ: CRDO) today announced the availability of its Ostrich 40G, PAM3 Serializer/Deserializer (SerDes) PHY/PMA...
- 575Wire Stories
Credo Introduces Industry Leading 40Gbps PAM3 SerDes Technology To Address New Markets Requiring High-speed, Low-Power Connectivity
SAN JOSE, Calif.–(BUSINESS WIRE)–Credo Technology Group Holding Ltd (NASDAQ: CRDO) today announced the availability of its Ostrich 40G, PAM3 Serializer/Deserializer (SerDes) PHY/PMA...
- 524Wire Stories
REA Group Hosts First Investor Day
Outlines Significant Growth Opportunities with Strong Momentum in Core Business and Adjacencies NEW YORK–(BUSINESS WIRE)–REA Group is targeting “double-digit revenue and EBITDA...
